Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $980.51 million. The enterprise value is $732.20 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 396.97 million shares outstanding. The number of shares has increased by 19.46% in one year.
| Current Share Class | 396.97M |
| Shares Outstanding | 396.97M |
| Shares Change (YoY) | +19.46% |
| Shares Change (QoQ) | +8.83% |
| Owned by Insiders (%) | 7.38% |
| Owned by Institutions (%) | 46.87% |
| Float | 338.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.27 |
| Forward PS | 2.59 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 2.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.41 |
| Quick Ratio | 2.92 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.89% and return on invested capital (ROIC) is -31.99%.
| Return on Equity (ROE) | -53.89% |
| Return on Assets (ROA) | -27.12% |
| Return on Invested Capital (ROIC) | -31.99% |
| Return on Capital Employed (ROCE) | -52.79% |
| Revenue Per Employee | $298,837 |
| Profits Per Employee | -$474,502 |
| Employee Count | 838 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 4.40 |
Taxes
| Income Tax | -697,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.72% in the last 52 weeks. The beta is 0.85, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -73.72% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 56.32 |
| Average Volume (20 Days) | 19,656,679 |
Short Selling Information
The latest short interest is 115.73 million, so 29.15% of the outstanding shares have been sold short.
| Short Interest | 115.73M |
| Short Previous Month | 95.42M |
| Short % of Shares Out | 29.15% |
| Short % of Float | 34.17% |
| Short Ratio (days to cover) | 5.90 |
Income Statement
In the last 12 months, IOVA had revenue of $250.43 million and -$397.63 million in losses. Loss per share was -$1.20.
| Revenue | 250.43M |
| Gross Profit | 51.82M |
| Operating Income | -411.33M |
| Pretax Income | -398.33M |
| Net Income | -397.63M |
| EBITDA | -375.79M |
| EBIT | -411.33M |
| Loss Per Share | -$1.20 |
Full Income StatementBalance Sheet
The company has $300.80 million in cash and $52.49 million in debt, giving a net cash position of $248.31 million or $0.63 per share.
| Cash & Cash Equivalents | 300.80M |
| Total Debt | 52.49M |
| Net Cash | 248.31M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 702.29M |
| Book Value Per Share | 1.82 |
| Working Capital | 303.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$323.14 million and capital expenditures -$28.68 million, giving a free cash flow of -$351.82 million.
| Operating Cash Flow | -323.14M |
| Capital Expenditures | -28.68M |
| Free Cash Flow | -351.82M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
Gross margin is 20.69%, with operating and profit margins of -164.25% and -158.78%.
| Gross Margin | 20.69% |
| Operating Margin | -164.25% |
| Pretax Margin | -159.06% |
| Profit Margin | -158.78% |
| EBITDA Margin | -150.06% |
| EBIT Margin | -164.25% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.46% |
| Shareholder Yield | -19.46% |
| Earnings Yield | -40.55% |
| FCF Yield | -35.88% |
Dividend DetailsAnalyst Forecast
The average price target for IOVA is $10.36, which is 319.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.36 |
| Price Target Difference | 319.43% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 43.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of -0.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.5 |
| Piotroski F-Score | 2 |
